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Abstract: The antioxidant activity of two synthesized coumarins namely, N-(4,7-dioxo-2-
phenyl-1,3-oxazepin-3(2H,4H,7H)-yl)-2-(2-oxo-2H-chromen-4-yloxy)acetamide  5  and  
N-(4-oxo-2-phenylthiazolidin-3-yl)-2-(2-oxo-2H-chromen-4-yloxy)acetamide  6  were 
studied with the DPPH, hydrogen peroxide and nitric oxide radical methods and compared 
with the known antioxidant ascorbic acid. Compounds 5 and 6 were synthesized in a good 
yield from the addition reaction of maleic anhydride or mercaptoacetic acid to compound 4， 
namely  N'-benzylidene-2-(2-oxo-2H-chromen-4-yloxy)acetohydrazide.  Compound  4  was 
synthesized by the condensation of compound 3, namely 2-(2-oxo-2H-chromen-4-yloxy) 
acetohydrazide,  with  benzaldehyde.  Compound  3,  however,  was  synthesized  from  the 
addition of hydrazine to compound 2, namely ethyl 2-(2-oxo-2H-chromen-4-yloxy)acetate, 
which was synthesized from the reaction of ethyl bromoacetate with 4-hydroxycoumarin 1. 
Structures  for  the  synthesized  coumarins  2–6  are  proposed  on  the  basis  of  
spectroscopic evidence.  
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1. Introduction 
Coumarin and its derivatives represent one of the most active classes of compound possessing a 
wide spectrum of biological activity [1–4]. Many of these compounds have proven to be active as 
antibacterial [5–7], antifungal [8], anti-inflammatory [9], anticoagulant [10], anti-HIV [11] and antitumor 
agents [12]. Coumarins are widely used as additives in food, perfumes, cosmetics [13], pharmaceuticals 
and optical brighteners [14] and would dispersed fluorescent and laser dyes [15]. Coumarins also have 
the super thermal stability and outstanding optical properties including extended spectral response, 
high quantum yields and superior photo stability. Optical applications of these compounds, such as 
laser  dyes,  nonlinear  optical  chromophores,  fluorescent  whiteners,  fluorescent  probes,  polymer 
science, optical recording and solar energy collectors have been widely investigated [16–20]. Classical 
routes  to  coumarins  incorporate  Pechmann,  Knoevenagel,  Perkin,  Reformatsky,  and  Wittig 
condensation reactions [21–24]. To make these classical reactions efficacious, several variations in 
terms of catalyst and reaction conditions have been introduced [25,26]. 4-Hydroxycoumarin and its 
derivatives have been effectively used as anticoagulants for the treatment of disorders in which there  
is  excessive  or  undesirable  cloterting,  such  as  thrombophlebitis  [27],  pulmonary  embolism  [28],  
and  certain  cardiac  conditions  [29].  Several  comparative  pharmacological  investigations  of  the  
4-hydroxycoumarin derivatives have shown it to have good anticoagulant activity combined with low 
side effects and little toxicity [30]. Antioxidants possess the ability to protect the cellular organelles 
from damage caused by free radicals induced oxidative stress. Free radicals used include hydroxyl 
radical,  superoxide  anion  radical  and  hydrogen  peroxide.  Highly  reactive  free  radicals  which  are 
formed by exogenous chemicals, stress or in the food system are capable of oxidizing biomolecules, 
resulting in cancer, coronary heart disease and hypertension [31]. Generally, most of the free radicals 
generated from metabolism are scavenged by endogenous defense system such as catalase, superoxide 
dismutase and peroxidase–glutathione system [32]. 
The  preparation  of  ethyl  2-(2-oxo-2H-chromen-4-yloxy)acetate  2,  which  was  used  as  a  starting 
material for the synthesis of compounds 5 and 6, is presented in this study. The chemical structures of 
the synthesized compounds 2–6 were conducted and confirmed. The in vitro antioxidant activities 
were investigated for the synthesized compounds 5 and 6. 
2. Results and Discussion 
2.1. Chemistry 
The reaction sequence for the synthesis of N-(4,7-dioxo-2-phenyl-1,3-oxazepin-3(2H,4H,7H)-yl)-2-
(2-oxo-2H-chromen-4-yloxy)acetamide  5  and  N-(4-oxo-2-phenylthiazolidin-3-yl)-2-(2-oxo-2H-
chromen-4-yloxy)acetamide 6, is out lined in Scheme 1. 
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Scheme 1. Reaction sequences of compounds 5 and 6. 
 
The synthesis of ethyl 2-(2-oxo-2H-chromen-4-yloxy)acetate 2 was conducted via reflux of Ethyl 
bromoacetate with 4-hydroxycoumarin 1 in the presence of anhydrous potassium carbonate in acetone. 
Hydrazinolysis of compound 2 with hydrazine hydrate produced hydrazide 3 in good yield. The FT-IR 
spectrum of compound 3 showed absorption bands in the 3297.3, 3211 cm
−1 (hydrazide NH-NH2), 
1711 cm
−1 (lactonic -C=O carbonyl stretching), and 1671.2 cm
−1 (amide -C=O carbonyl stretching).  
The 
1H-NMR spectrum exhibited a singlet due to the -CO-NH-NH2 proton at δ 8.89 ppm. Compound 3 
was  thencondensed  with  benzaldehyde  to  make  compound  4  that  can  be  cyclized  with  maleic 
anhydride (or mercaptoacetic acid)to yield compounds 5 (and 6). The IR spectrum of compound 4 
showed characteristic  bands at 3191.1  cm
−1 (NH), 1734.3 (C=O, lactone) cm
−1,  1688 cm
−1 (C=O, 
amide). The 
1H-NMR spectrum showed the absence of NH2 protons, and the presence of the N=CH 
proton at 8.23 ppm. Compound 5 shows pronounced peaks; a singlet due to the NH proton at 9.58 in 
addition  to  a  singlet  for  1H  assigned  to the  (-C=C-H).  The  IR  spectrum  of  compound  6  showed 
characteristic  bands at 3198.7 cm
−1, 29211731 cm
−1, and 1689 and1667 cm
−1 (NH), (C-H alkane), 
(C=O, lactone) and (C=O, amide) respectively. The 
1H-NMR spectrum of compound 6 showed peaks 
at 5.87 ppm (s, 1H) =C-H and 3.91 (d, 2H, CH2).  
The reaction of compound 4  with  maleic anhydridecould  be  visualized through the  mechanism 
shown in Scheme 2. Int. J. Mol. Sci.2011, 12                     
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Scheme 2. Mechanism of formation of compound 5. 
 
2.1.1. Computational Studies  
An earlier study [33] has shown that atomic charges were affected by the presence of the substituent 
of rings. With the aid of a reference model, compound anoptimized geometry and the 3D geometrical 
structureis  given  in  Figure  1  and  Table  1,  respectively.  The  data  obtained  show  that  the  heat  of 
formation  are  about  81.154956  kJ/mol)  and  the  highest  atomic  charge  in  compound  5  is  
at  [O(12)  −0.510]  followed  by  the  next  charge  value  at  [O(10)  −0.509]  and  [O(15)  (−0.437)].  
These data show clearly that these three atoms are the most reactive toward the addition, substitution 
reactions and bonding with the metal. The determined bond angle and twist angle, stretch (1.4560), 
bend (4.3225), stretch-bend (−0.1213). The 3D geometrical structure indicates that this molecule is a 
non-planarmolecular and the stereochemistry is [C(18): (S); C(19)-C(20): (E); C(7)-C(8): (Z)]. 
Figure 1. Optimized 3D geometrical structure for compound 5. 
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Table 1. Atomic charge (Mulliken atomic charges) of synthesized compound 5. 
Atom  Charge  Atom  Charge  Atom  Charge  Atom  Charge 
C (1)  0.044  C (13)  −0.138  C (25)  0.110  H (37)  0.189 
C (2)  0.365  C (14  0.549  C (26)  −0.203  H (38)  0.188 
C (3)  −0.196  O (15)  −0.437  C (27)  −0.112  H (39)  0.325 
C (4)  −0.111  N (16)  −0.400  C (28)  −0.117  H (40)  0.182 
C (5)  −0.125  N (17)  −0.264  C (29)  −0.112  H (41)  0.161 
C (6)  −0.180  C (18)  0.185  C (30)  −0.180  H (42)  0.165 
C (7)  413  C (19)  −0.160  O (31)  −0.465  H (43)  0.188 
C (8)  −0.339  C (20)  −0.159  H (32)  0.147  H (44)  0.126 
C (9)  0.556  C (21)  0.517  H (33)  0.130  H (45)  0.122 
O (10)  −0.509  C (22)  0.560  H (34)  0.126  H (46)  0.123 
O (11)  −0.426  O (23)  −0.499  H (35)  0.147  H (47)  0.152 
O (12)  −0.510  O (24)  −0.411  H (36)  0.183  -  - 
2.2. Pharmacology 
2.2.1. Antioxidant Activity  
Antioxidant  compounds  in  food  play  an  important  role  as  a  health-protecting  factor.  Scientific 
evidence suggests that antioxidants reduce the risk for chronic diseases including cancer and heart 
disease. Primary sources of naturally occurring antioxidants are whole grains, fruits and vegetables. 
Plant-sourced  food  antioxidants  like  vitamin  C,  vitamin  E,  carotenes,  phenolic  acids,  phytate  and 
phytoestrogens  have  been  recognized  as  having  the  potential  to  reduce  disease  risk.  Most  of  the 
antioxidant compounds in a typical diet are derived from plant sources and belong to various classes of 
compounds  with  a  wide  variety  of  physical  and  chemical  properties.  Some  compounds,  such  as 
gallates,  have  strong  antioxidant  activity,  while  others,  such  as  the  mono-phenols  are  weak 
antioxidants [34]. The role of antioxidant is to remove free radicals. One important mechanism through 
which this is achieved is by donating hydrogen to free radicals in its reduction to non-reactive species. 
Addition  of  hydrogen  would  remove  the  odd  electron  feature  which  is  responsible  for  radical 
reactivity. Free radicals have been a subject of significant interest among scientists in the past decade. 
Their broad range of effects in biological systems has drawn the attention of many workers. It has been 
proven that free radicals play an important role in the pathogenesis of certain diseases and aging. There 
are many reports that support the use of antioxidant supplementation in reducing the level of oxidative 
stress and in slowing or preventing the development of complications associated with diseases [35]. 
Many synthetic antioxidant components have shown toxic and/or mutagenic effects, and there-fore 
attention has been paid to naturally occurring antioxidants. Compound 5 and 6 were screened for in vitro 
antioxidant activity using (1,1-diphenyl-2-picrilhydrazyl) DPPH, Nitric oxide and hydrogen peroxide. 
They  show  good  antioxidant  activity  against  all  methods  (Figures  2–4).  The  hydrogen-donating 
activity,  measured  using  DPPH  radicals  as  hydrogen  acceptor,  showed that  significant  association 
could be found  between the concentration of the novel  molecule and the percentage of inhibition. 
Through  DPPH  test,  compounds  5  and  6  have  down  to  reduce  the  stable  radical  DPPH  to  the  
yellow-colored diphenylpicrylhydrazine. The method was based on the reduction of alcoholic DPPH 
solution in the presence of a hydrogen-donating antioxidant due to the formation of the non-radical Int. J. Mol. Sci.2011, 12                     
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form  DPPH-H  in  the  reaction  [36].  The  nitric  oxide  assay  has  been  widely  used  to  evaluate  the 
effectiveness of the free radical scavenging on various antioxidant substances. Nitric oxide generated 
as a result of decomposition of sodium  nitroprusside  in aqueous  medium  interacts with oxygen at 
physiological pH to produce nitrite ions. The nitrite ions were subjected to diazotization followed by 
azo coupling reaction to yield an azo dye measured by an absorption band at 540 nm. The scavenging 
ability of the synthesized compounds 5 and 6 was compared with ascorbic acid as a standard. Nitric 
oxides radical inhibition study showed that the synthesized compounds were a potent scavenger of 
nitric oxide. The compounds 5 and 6 inhibited nitrite formation by competing with oxygen to react 
directly with nitric oxide and also to inhibit its synthesis. Scavengers of nitric oxide competed with 
oxygen, leading to the reduced production of nitric oxide [37]. 
There are two postulated mechanisms for the reaction of compound 5 as an antioxidant as shown in 
Schemes 3 and 4. The first mechanism depends on the benzyl hydrogen atom (bold hydrogen atom), 
where  this  atom  was  under  the  influence  of  two  effects,  namely  resonance  and  inductive.  The 
resonance effect of benzyl hydrogen makes the release of hydrogen as a free radical easy while the 
inductive  effect  on  benzene  ring,  oxygen  and  nitrogen  pushes  the  electrons  toward  a  carbon  free 
radical, resulting in the molecule becoming stable. 
Figure 2. Effect of compound 5 and 6 toward 1,1-diphenyl-2-picrilhydrazyl (DPPH). 
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Figure 3. Effect of compound 5 and 6 toward nitric oxide. 
 
Figure 4. Effect of compound 5 and 6 toward hydrogen peroxide. 
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Scheme 3. Suggested mechanism for compound 5 as antioxidant. 
 
The second postulated mechanism fellows the route of the keto-enol forms as shown in Scheme 4. 
Scheme 4. Suggested mechanism for compound 5 fellow the route of the keto-enol forms. 
 
For compound 6,  the two suggested mechanisms depend on the keto-enol  form as depicted on 
Schemes 5 and 6. 
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Scheme 5. Suggested mechanism for compound 6 fellow the route of the keto-enol forms. 
 
Scheme 6. Suggested mechanism for compound 6 fellow the route of the keto-enol forms 
 
3. Experimental Section 
3.1. General 
All  chemicals  used  were  of  reagent  grade  (supplied  by  either  Merck  or  Fluka)  and  used  as  
supplied without further purifications. The FTIR spectra were recorded as KBr disc on FTIR 8300 
Shimadzu  Spectrophotometer.  The  UV-Visible  spectra  were  measured  using  Shimadzu  UV-VIS.  
160A spectrophotometer. Proton NMR spectra were recorded on Bruker - DPX 300 MHz spectrometer 
with TMS as the internal standard. Elemental micro analysis was carried out using a CHN elemental 
analyzer model 5500-Carlo Erba instrument. 
3.2. Chemistry 
3.2.1. Synthesis of Ethyl 2-(2-oxo-2H-chromen-4-yloxy)acetate 2 
A suspension of 4-hydroxycoumarins 1 (6.17 mmol) in acetone (30 mL) was refluxed with ethyl 
bromoacetate (9.15 mmol) and K2CO3 (4.69 g, 33.91 mmol) for 12 h. After cooling, the mixture was 
evaporated to dryness and the residue was partitioned between CHCl3 (50 mL) and water (50 mL).  Int. J. Mol. Sci.2011, 12                     
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The  organic  phase  was  dried  (Na2SO4),  filtered  and  evaporated  to  dryness.  The  residue  was 
recrystallized from acetone; yield 92%; m.p. 99.0 °C; 
1H-NMR (CDCl3): δ 3.22 (t, 3H, CH3), δ 3.85  
(m, 2H, CH2), δ 4.91 (s, 2H) and δ 5.20, δ 5.250, δ 5.272 (s, 2H) for CH2), δ 5.78 (s, 1H) for -C=C-H), 
δ 7.291, δ 7.478, δ 7.80 (s, 1H) for aromatic ring); 
13C-NMR: 167.2; 165.1; 163.4, 155.9; 134.2; 121.8; 
121.1;  119.0;  113.8;  100.9;  65.3;  54.7;  22.12;  IR:  2987.3  cm
−1  (C-H,  Aliphatic),  
3089.5 cm
−1 (C-H, Aromatic), 1759.3 cm
−1 (C=O, Lactonic), 1717.6 cm
−1 (C=O, Estric), 1629.2 cm
−1 
(C=C,  Alkene),  1577.6  cm
−1  (C=C,  Aromatic);  Theoretical  Calculation  for  C13H12O5:  C  62.90%,  
H 4.87%. Experimental: C 61.91% H 3.99%. 
3.2.2. Synthesis of 2-(2-oxo-2H-chromen-4-yloxy)acetohydrazide 3 
A  solution  of  compound  2  (10  mmol)  in  ethanol  25  mL  was  refluxed  with  hydrazine  hydrate  
(15  mmol)  for  4  h.  After  concentrating  the  reaction  mixture  a  solid  mass  separated  out  and 
recrystallized  using  ethanol,  yield  51%,  m.p.  228  °C; 
1H-NMR  (CDCl3):  δ  4.48  (s,  2H,  CH2),  
δ 4.65 (s, 2H, NH2), δ 8.89 (s, 1H, NH), δ 4.92 (s, 2H) and δ 5.210 (s, 2H) for (O-CH2), δ 5.72 (s, 1H) 
for  (-C=C-H),  δ  7.410,  δ  7.521,  δ  8.10  (s,  1H)  for  aromatic  ring;  IR:  3297.3,  3211  cm
−1  (N-H),  
2906.0 cm
−1 (C-H, Aliphatic), 3072.7 cm
−1 (C-H, Aromatic), 1711.5 cm
−1 (C=O, Lacton), 1671.2 cm
−1 
(C=O,  Amide);  Theoretical  Calculation  for  C11H10N2O4:  C  56.41%,  H  4.30%,  N  11.96%. 
Experimental: C 57.13% H 4.01%, N 10.52%. 
3.2.3. Synthesis of N'-benzylidene-2-(2-oxo-2H-chromen-4-yloxy)acetohydrazide 4 
A  solution  of  the  compound  3  (0.2  mmol)  in  ethanol  25  mL  was  refluxed  with  benzaldehyde  
(0.2 mmol) for 20 h. After cooling to room temperature, a solid mass separated and recrystallized. 
Recrystallized from ethanol;yield 57%; m.p. 258 °C; 
1H-NMR (CDCl3): δ 8.23, (s, 1H,N=CH), δ 8.11 
(s, 1H, NH), δ 4.91 (s, 2H) and δ 5.340 (s, 2H) for O-CH2), δ 5.67 (s, 1H) for (-C=C-H), δ 7.240,  
δ 7.312, δ 7.97 (s, 1H) for aromatic ring;
 13C-NMR (DMSO-d6): 170.0, 169.2, 164.1, 155.1,145.6, 
136.9,129,8, 128, 125, 120.6, 119.9, 118.4,118.3, 117.9, 80.1, 65.2; IR: 3191.1cm
−1 (N-H), 2901.0 cm
−1 
(C-H,  Aliphatic),  3058.2  cm
−1  (C-H,  Aromatic),  1743.3  cm
−1  (C=O,  Lacton),  1688  cm
−1  (C=O, 
Amide), 1613 cm
−1 (C=N), 1627.7 cm
−1 (C=C); Theoretical Calculation for C18H14N2O4: C 67.07%,  
H 4.38%, N 8.69%. Experimental: C 66.39% H 3.95%, N 7.97%. 
3.2.4. Synthesis of N-(4,7-dioxo-2-phenyl-1,3-oxazepin-3(2H,4H,7H)-yl)-2-(2-oxo-2H-chromen-4-yloxy) 
acetamide 5 
Mixture of 1 mmole of compound 4 with 1 mmole of maleic anhydride in 50 mL of dry benzene 
was refluxed in water bath for 20 h. The solvent was removed and the precipitate was recrystallized 
from  tetrahydrofuran;  yield  44%;  m.p.  201  °C; 
1H-NMR  (CDCl3):  δ  3.93  and  4.22  
(dd, 2H, CH2), δ 9.58 (s, 1H, NH), δ 4.81 (s, 2H) and δ 5.350 (s, 2H) for O-CH2), δ 6.11 (s, 1H) for  
(-C=C-H), δ 7.320, δ 7.412, δ 7.79 (s, 1H) for aromatic ring; 
13C-NMR (DMSO-d6): 170.4, 167.2, 
165.8,  160.6,  155.1,  155.4,  139.4,  136,  128.8,  125.8,  124.3,  120.6,  119.6,  117.1,  116.3  115.3, 
113,100.6,  69.9,  55.4;  IR:  3232.1cm
−1  (N-H),  2979.5  cm
−1  (C-H,  Aliphatic),  3097.3  cm
−1  (C-H, 
Aromatic), 1765, 1741 cm
−1 (C=O), 1671 cm
−1 (C=O, amide), 1617.8 cm
−1 (C=N), 1632.6 cm
−1 (C=C, Int. J. Mol. Sci.2011, 12                     
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Aromatic); Theoretical Calculation  for C22H16N2O7: C 62.86%, H 3.84%, N 6.66%. Experimental:  
C 61.99% H 3.72%, N 5.90%. 
3.2.5. Synthesis of N-(4-oxo-2-phenylthiazolidin-3-yl)-2-(2-oxo-2H-chromen-4-yloxy)acetamide 6 
Mixture of 0.01 mole of Schiff base with 0.01 of mercaptoacetic acid in 50 mL of dry benzene was 
refluxed in water bath for 20 hours., filtered off, washed with water, dried and recrystallized from 
dichloromethane; yield 70%; m.p. 261 °C; 
1H-NMR (CDCl3): δ 3.83 (, 2H, CH2), δ 5.40 (s, S-CH),  
δ 8.98 (s, 1H, NH), δ 4.77 (s, 2H) and δ 5.110 (s, 2H) for O-CH2), δ 5.82 (s, 1H) for (-C=C-H),  
δ 7.320, δ 7.441, δ 7.92 (s, 1H) for aromatic ring;
 13C-NMR (DMSO-d6): 171, 169.0, 167.8, 154.1, 
159.8,  128.2,  127.8,  126.1,  124.3,  120.1,  117.1,  114.4,  112.9,110.1  101.4,  77.6,  65.4,  33.2;  IR: 
3198.7cm
−1  (N-H),  2921  cm
−1  (C-H,  Aliphatic),  3087.7  cm
−1  (C-H,  Aromatic),  1731  cm
−1  (C=O, 
Lacton), 1689, 1667 cm
−1 (C=O, amide), 1622 cm
−1 (C=N), 1632.8 cm
−1 (C=C, Aromatic); Theoretical 
Calculation  for  C20H16N2O5S:  C  60.60%,  H  4.07%,  N  7.07%.  Experimental:  C  60.41%  H  3.91%,  
N 6.88%. 
3.3. Pharmacology 
3.3.1. (2,2-diphenyl-1-picrylhydrazyl) (DPPH) Radical Scavenging Activity 
The DPPH radical scavenging activities of the test samples compounds (5 and 6) were evaluated 
according to Soares, et al [38]. Initially, 0.1 mL of the samples at concentration of 250, 500, 750 and 
1000 μg/mL was mixed with 1 mL of 0.2 mM DPPH that was dissolved in methanol. The reaction 
mixture was incubated in the dark for 20 min at 28 °C. The control contained all reagents without the 
sample while methanol was used as blank. The DPPH radical scavenging activity was determined by 
measuring  the  absorbance  at  517  nm  using  the  UV-VIS  spectrophotometer.  The  DPPH  radical 
scavenging activity of ascorbic acid was also assayed for comparison. 
The percentage of DPPH radical scavenger was calculated using Equation 1. 
Scanvenging
0 1
0
(%) 100
A A
effect
A

    (1) 
where A0 is the absorbance of the control reaction and A1 is the absorbance in the presence of the 
samples or standards. 
3.3.2. Nitric Oxide Scavenging Activity 
Sodium nitroprusside in aqueous solution at physiological pH generates nitric oxide spontaneously; 
it  interacts  with  oxygen  to  produce  nitrite  ions,  which  can  be  estimated  by  the  use  of  
GriessIllosvoy reaction [39]. In the present investigation, GriessIllosvoy reagent was modified using 
naphthylethylenediaminedihydrochloride (0.1% w/v) instead of 1-naphthylamine (5%). The reaction 
mixture (3 mL) containing sodium nitroprusside (10 mM, 2 mL), phosphate buffer saline (0.5 mL) and 
compounds 5 and 6 (250, 500, 750 and 1000 μg/mL) or standard solution (0.5 mL) was incubated at  
25 °C for 150 min. After the incubation, 0.5 mL of the reaction mixture containing nitrite was pipetted 
and mixed with 1 mL of sulphanilic acid reagent (0.33% in 20% glacial acetic acid) and allowed to Int. J. Mol. Sci.2011, 12                     
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stand for 5 min for completing diazotization. Then, 1 mL of naphthylethylenediaminedihydrochloride 
(1%) was added, mixed and allowed to stand for 30 min. A pink-colored chromophore was formed in 
diffused light. The absorbance of these solutions was measured at 540 nm against the corresponding 
blank.  Ascorbic  acid  was  used  as  standard.  Nitric  oxide  percentage  scavenging  activity  was  then 
calculated using Equation 1. 
3.3.3. Hydrogen Peroxide Scavenging Activity 
A solution of hydrogen peroxide (40 mM) was prepared in phosphate buffer (pH 7.4). Different 
concentrations ((250, 500, 750 and 1000 μg/mL)) of synthesized compounds (or ascorbic acid) were 
added to a hydrogen peroxide solution (0.6 mL, 40 mM). Absorbance of hydrogen peroxide at 230 nm 
was determined after 10 min. against a blank solution containing phosphate buffer without hydrogen 
peroxide  [40,41].  Hydrogen  peroxide  percentage  scavenging  activity  was  then  calculated  using 
Equation 1. 
3.4. DFT 
The molecular sketch of the reference compound was plotted using Visualization Materials Studio 
5.5 software. All quantum chemical calculations were performed using the Density Functional Theory 
(DFT) in the methodology. DMol
3 model was employed to obtain quantum chemical parameters and 
optimization  of  the  molecule  geometry.  Molecular  atomic  charges  were  calculated  by  Mulliken 
population analysis. 
4. Conclusions 
In this study, the two coumarins, namely N-(4,7-dioxo-2-phenyl-1,3-oxazepin-3(2H,4H,7H)-yl)-2-
(2-oxo-2H-chromen-4-yloxy)acetamide  and  N-(4-oxo-2-phenylthiazolidin-3-yl)-2-(2-oxo-2H-chromen-
4-yloxy)acetamide,  have  been  successively  synthesized,  and  characterized  by  using  various 
spectroscopic  methods  and  elemental  analysis  techniques.  Two  postulated  mechanisms  have  been 
proposed for the action of compound as antioxidant. The antioxidant activity of the compounds was 
initially tested and showed that the compounds have improved properties compared to ascorbic acid. 
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